Lupus Clinical Trial - A Study to Determine the Pharmacokinetic Profile of

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06013995` - A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus	Phase 1
Recruiting	`NCT03952624` - Patient-Centered Assessment of Symptoms and Outcomes
Terminated	`NCT01389895` - Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus	Phase 1
Completed	`NCT00710021` - Vitamin D3 in Systemic Lupus Erythematosus	Phase 2
Completed	`NCT02265744` - Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus	Phase 2
Completed	`NCT00581763` - Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies	N/A
Recruiting	`NCT01172002` - Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis	N/A
Completed	`NCT00299819` - Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)	Phase 1
Completed	`NCT00054938` - Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)	Phase 2
Terminated	`NCT03953690` - Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
Recruiting	`NCT05715463` - Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity	N/A
Enrolling by invitation	`NCT05321108` - Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus	N/A
Completed	`NCT00482989` - A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus	Phase 1
Completed	`NCT00657189` - A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus	Phase 2
Recruiting	`NCT04334031` - Deployment o the Multidisciplinary Prospective Cohort Imminent	N/A
Completed	`NCT03402087` - A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients	Phase 1
Completed	`NCT02857452` - Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire	N/A
Terminated	`NCT03186794` - Aerobic Exercise in Women With Systemic Lupus Erythematosus	N/A
Recruiting	`NCT05922722` - Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
Completed	`NCT03093402` - JBT-101 in Systemic Lupus Erythematosus (SLE)	Phase 2

NCT number	NCT04065932
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 1
Start date	August 22, 2019
Completion date	December 10, 2019

A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms